Antibody Therapeutics Impact Factor, Indexing, Ranking

Antibody Therapeutics Impact Factor, Indexing, Ranking

Antibody Therapeutics (Ar) is a scholarly journal dedicated to publishing research in the field of Medicine. Oxford University Press is the publisher of this esteemed journal. and its abbreviated form is Antib Ther.

Aim and Scope

A peer-reviewed, online, open access journal, Antibody Therapeutics provides a forum for the publication of the latest advances and challenges in the discovery, research, development, manufacturing, and methodology of therapeutic antibodies for the global scientific community. Topics include target and antibody discovery, mechanistic research, new technologies and methods, manufacturing, clinical trials, regulation, policies, and more. Antibody Therapeutics article types include original research, reviews, cutting-edge technologies, new methods, news, interviews, and meeting highlights.

Journal Details

Journal title Antibody Therapeutics (Ar)
Abbreviation Antib Ther
Online ISSN 2516-4236
Publisher Name Oxford University Press
Editor-in-chief Mitchell Ho
Subject Category Medicine


Abbreviation : ISO Journal abbreviation refers to the shortened form or acronym used to represent the full title of a scholarly journal. The ISO4 Abbreviation of Antibody Therapeutics Journal is Antib Ther.


The Ranking of the Journal in 2024 is 1807. Ranking systems aim to provide an indication of a journal's quality, influence, and prestige within a specific field or discipline.

Impact Factor

At present, the Antibody Therapeutics's Impact Factor is unavailable as the journal is not yet indexed in the Web of Science (WOS). Rest assured, as soon as the impact factor becomes available, we will promptly update this information. Please stay tuned for updates regarding this matter.

List of All Journal Impact Factors


The Journal SCImago in 2024 is 1.648. It is measured by the number of citations which are made by the particular journals, and the journal from where the citations arrived from.


The Journal's H-Index in 2024 is 16. The H-index is calculated on how many times a particular author is cited and the number of published papers that a particular author has.


The Journal's Quartile is Q1. A quartile has three points, which are the upper quartile, median, and lower quartile. The main motive of the quartile is to calculate the interquartile range, that resembles the changes across the median.

Journal's Indexing

The Journal is indexed in (Indexing details)

PubMed Scopus Web of Science UGC Embase DOAJ

Indexing services aim to make it easier for researchers, scholars, and readers to discover and access articles from various journals within a specific field or discipline.

Journal's Metrics for 2024

Abbreviation Antib Ther
Access type Open Access
SJR 1.648
SNIP 0.667
Ranking 1807
CiteScore 6.4
H-Index 16

Editorial Board

The Editor-in-chief of the Journal is Mitchell Ho

Submission/Processing Fee (APC)

Processing/Submission Fee : Article submission/Processing fees (APC), also known as manuscript Publication fees or processing fees (APC), are charged by journals to authors for submitting/publishing their research papers/article.

The APC/Submission (Publication) Fee of the Journal is Non Member 2687 USD, For Member 2142

Call for paper

Call for paper : The Journal invites original research contributions for consideration of publication in Antibody Therapeutics journal.

Journal seeking submissions in the broad areas of Medicine that align with journal's focus on Medicine.

for details about call for paper please visit to the official website of the journal to check the details about call for papers.

How to publish in Antibody Therapeutics

Publishing in Antibody Therapeutics involves the following steps:

  • Research: Conduct high-quality, impactful research in the field of Medicine.
  • Familiarize Yourself: Read and understand the aims and scope of Antibody Therapeutics to ensure your work aligns with their focus.
  • Manuscript Preparation: Prepare your manuscript according to the Antibody Therapeutics guidelines, including formatting, length, and referencing style.
  • Submission: Submit your manuscript through the journal's online submission system.

Antibody Therapeutics FAQ

is journal indexed in PubMed?

Yes, the journal is indexed in PubMed.

is journal indexed in Scopus?

Yes, the journal is indexed in Scopus.

is journal indexed in UGC?

Yes, the journal is indexed in UGC.

is journal indexed in Index Copernicus?

No, the journal is not indexed in Index copernicus.

is a predatory journal?

No, journal is not a predatory journal.

What is the Imptact Factor of Antibody Therapeutics?

The Journal is not indexed in WOS, so the journal doesn't have a Impact Factor.

What is the Ranking of the Journal?

The Ranking of the Journal is 1807.

is journal peer reviewed?

Yes the journal is a peer-reviewed journal.

is Antibody Therapeutics a good journal?

Yes the journal is a peer-reviewed journal and good to publish your paper.

What is Antibody Therapeutics?

Antibody Therapeutics (Ar) is a scholarly journal dedicated to publishing research in the field of Medicine. Oxford University Press is the publisher of this esteemed journal.

is Antibody Therapeutics open access?

Yes, Antibody Therapeutics is a open access journal.

Table of Contents

Search For Journals, Indexing, Impact Factor etc.